CTLA-4 VARIANTEN

Patent europeic · EP3207938 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3207938
Numer da la dumonda
EP17163638
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-03-2013
Publitgà
23-08-2017
Concedì
25-12-2019
La protecziun finescha il pli tard
10-03-2033
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C07K 14/705 (2006.01)
A61K 38/00 (2006.01)
Prioritad
US 201261645686 P 11.05.2012
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 25-12-2019

    Concedì

    Published in Swissreg on 25.12.2019

Partidas

Possessur

Medimmune Limited

MedImmune Limited

Milstein Building Granta Park, Cambridge CB21 6GH, GB

Inventur

MINTER, Ralph

Cambridge, Cambridgeshire CB21 6GH, GB

DOUTHWAITE, Julie

Cambridge, CB21 6GH, GB

PRIVESENTZEV, Cyril

Cambridge, CB21 6GH, GB

MOISAN, Jacques

Gaithersburg, Maryland 20878, US

BOWEN, Michael

Gaithersburg, Maryland 20878, US

RUST, Steven

Cambridge, Cambridgeshire CB21 6GH, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.